Psychiatric and substance use disorders amid the COVID-19 pandemic

The COVID-19 pandemic has profoundly disrupted people’s daily lives, leading to a rise in mental health and substance abuse concerns. It has also led to a rise in life insurance applications. Underwriters who understand the complex interplay between psychiatric disorders and mortality are better equipped to assess risk. Join our complimentary one-hour webinar for a review of recent data and the latest risk assessment resources so you can make better-informed underwriting decisions.

Topics covered

• Socioeconomic impacts of COVID-19
• Mental health and substance use disorders amid the pandemic
• Tools that instantly identify and index psychiatric disorders during underwriting
• Sample cases

Who should attend

This session is intended for medical directors, underwriters, and other clinical and insurance professionals who want to heighten their understanding and interpretation of mental health and substance use disorder risks.

Presenter

Hayley Vrchota, PharmD, CTTS

Pharmacy Consultant